Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection

Gastroenterology

Volumn 123, Issue 5, 2002, Pages 1494-1499

  Alric, Laurent ^a,c   DiMartino, Vincent ^e   Duffaut, Michel ^a   Cacoub, Patrice ^b   Piette, Feédéric Charlotte ^e   Vinel, Jean Pierre ^b   Piette, Jean Charles ^e   Durand, Dominique ^d   Rostaing, Lionel ^d   Poynard, Thierry ^e  

^a institut universitaire du cancer   (France)

^b CHU PURPAN   (France)

^c Laboratoire Macrophages   (France)

^d CHU RANGUEIL   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0036829111     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.36610     Document Type: Article

References (21)

1. Izopet J, Rostaing L, Moussion F, Airic L, Dubois M, That HT, Payen JL, Duffaut M, Durand D, Suc JM, Puel J. High rate of hepatitis C virus clearance in hemodialysis patients after interferon-α therapy. J Infect Dis 1997;176:1614-1617.
2. Martin P, Carter D, Fabrizi F, Dixit V, Conrad AJ, Artinian L, Peacock V, Han S, Wilkinson A, Lassman CR, Danovitch G. Histopathological features of hepatitis C in renal transplant candidates. Transplantation 2000;69:1479-1484.
3. Glicklich D, Thung SN, Kapoian T, Tellis V, Reinus JF. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients. Am J Gastroenterol 1999;94:159-163.
4. Izopet J, Pasquier C, Sandres K, Puel J, Rostaing L. Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J Med Virol 1999;58:139-144.
5. Legendre C, Garrigue V, Le Bihan C, Mamzer-Bruneel MF, Chaix ML, Landais P, Kreis H, Pol S. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipient. Transplantation 1998;65:667-670.
6. Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, Fretz C, Thibault V, Cadranel JF, Bernard B, Opolon P, Coriat P, Bitker MO. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999;29:257-263.
7. Lunel F, Cadranel JF, Rosenheim M, Dorent R, Di-Martino V, Payan C, Fretz C, Ghoussoub JJ, Bernard B, Dumont B, Perrin M, Gandjbachkh I, Huraux JM, Stuyver L, Opolon P. Hepatitis virus infection in heart transplant recipients: Epidemiology, natural history, characteristics, and impact on survival. Gastroenterology 2000;119:1064-1074.
8. Kliem V, van den Hoff U, Brunkhorst R, Tillmann HL, Flik J, Manns MP, Pichlmayr R, Koch KM, Frei U. The long term course of hepatitis C after kidney transplantation. Transplantation 1996;62:1417-1421.
9. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchinson J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001;34:730-739.
10. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-832.
11. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435.
12. The French METAVIR Cooperative Group, Bedossa P. Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. Hepatology 1994;20:15-20.
13. Alric L, Duffaut M, Selves J, Sandre K, Mularczyck M, Izopet J, Desmorat H, Bureau C, Chaouche N, Dalbergue B, Vinel JP. Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: Results of a randomized trial. J Hepatol 2001;35:272-278.
14. Daghestani L, Pomeroy C. Renal manifestations of hepatitis C infection. Am J Med 1999;106:347-354.
15. Roth D, Zucker K, Cirocco R, Burke G, Ciancio G, Esquenazi V, Swanson SJ 3rd, Miller J. A prospective study of hepatitis C virus infection in renal allograft recipients. Transplantation 1996;61:886-889.
16. Rostaing L, Izopet J, Cisterne JM, Arnaud C, Duffaut M, Rumeau JL. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients. Transplantation 1998;65:930-936.
17. DeMatos A, Rosen HR. To C or not to C: These are the questions in renal transplantation. Transplantation 2000;69:1236-1237.
18. Papatheoridis CV, Davies S, Dhillon AP, Teixeira R, Goulis J, Davidson B. The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis. Transplantation 2001;72:412-418.
19. David-Neto E, Americo Da Fonseca J, Jota de Paula F, Nahas WC, Sabbaga E, Ianhez LE. The impact of azathioprine on chronic viral hepatitis in renal transplantation: A long-term, single-center, prospective study on azathioprine withdrawal. Transplantation 1999;68:976-980.
20. Izopet J, Rostaing L, Sandres K, Cisterne JM, Pasquier C, Rumeau JL, Duffaut M, Durand D, Puel J. Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients. J Infect Dis 2000;181:852-858.
21. Hanafusa T, Ichikawa Y, Kishikawa H, Kyo M, Fukunishi T, Kokado Y, Okuyama A, Shinji Y, Nagano S. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998;66:471-476.